Excelart boasts CV imaging
Cardiovascular capabilities available on Toshiba's ultracompact high-field MR system were highlighted at the annual meeting of the American College of Cardiology, March 7 to 10 in New Orleans. Vantage, which was formally released at the 2003 RSNA
Cardiovascular capabilities available on Toshiba's ultracompact high-field MR system were highlighted at the annual meeting of the American College of Cardiology, March 7 to 10 in New Orleans. Vantage, which was formally released at the 2003 RSNA meeting, supports a range of CV studies from stroke evaluation to peripheral vascular imaging. The ultrashort bore provides a feeling of openness; Pianissimo technology reduces scan noise. SuperFASE supports morphology studies of vascular structures, including the heart chambers and large vessels, as well as MR angiograms of venous and arterial vessels. Toshiba's parallel imaging technology, called Speeder, allows high-speed, high-resolution imaging, cutting exam time by as much as a factor of three.
Study Shows No Impact of Hormone Therapy on PET/CT with 18F-Piflufolastat in PCa Imaging
May 7th 2025For patients with recurrent or metastatic prostate cancer, new research findings showed no significant difference in the sensitivity of 18F-piflufolastat PET/CT between patients on concurrent hormone therapy and those without hormone therapy.
